Who is sponsoring NCT04721405?

NCT04721405 is sponsored by Nanowear Inc..

What drugs are being tested in NCT04721405?

Interventions in NCT04721405: Observational Study: No intervention.

What condition does NCT04721405 study?

NCT04721405 studies Elective Surgical Procedures.

Is NCT04721405 still recruiting?

NCT04721405 is currently completed. Last updated 9 April 2026.

Last reviewed 2026-04-09 · How we verify

NCT04721405

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Non-Invasive Assessment for Post RFAL Procedure Monitoring Using the Nanowear Wearable Multiple Sensor Vest

Completed Last updated 9 April 2026

What this trial tests

trial testing Observational Study: No intervention in Elective Surgical Procedures in 44 participants. Completed in 30 April 2021.

Timeline

14 September 2020

Primary endpoint
30 April 2021

30 April 2021

Quick facts

Lead sponsor	Nanowear Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	44
Start date	14 September 2020
Primary completion	30 April 2021
Estimated completion	30 April 2021
Sites	1 location across United States

Drugs / interventions tested

Observational Study: No intervention

Conditions studied

Elective Surgical Procedures — all drugs for Elective Surgical Procedures →

Sponsor

Nanowear Inc.

Who can join

18 and older, any sex, with Elective Surgical Procedures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate an experience of post-operative monitoring using the Nanowear wearable multiple sensor vest in plastic surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Elective Surgical Procedures

Currently open trials in the same condition.

NCT05841667 — Impact of CES1 Genotype on Remimazolam · recruiting
NCT04894864 — Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair · Phase 4 · recruiting

Other Nanowear Inc. trials

Trials by the same sponsor.

NCT05629533 — The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output · terminated
NCT04717024 — The Nanowear Wearable Covid-19 Observational and Analysis Trend · terminated
NCT03719079 — Nanowear Heart Failure Management Multi-sensor Algorithm · terminated
NCT05473702 — Smart Textile Sensor System for Health Monitoring · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04721405 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nanowear Inc.
Last refreshed: 9 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04721405.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing